Teva Gets Mixed Rulings in Antitrust Cases Involving MS Drug

Teva Pharmaceuticals Industries Ltd. dodged some claims and will continue to litigate others in multidistrict litigation brought by drug wholesalers and retailers, as well as a suit brought by a rival ...

Teva must face Mylan lawsuit over generic competition for Copaxone

Teva Pharmaceutical must face a lawsuit claiming it used unlawful methods to block generic competition for its multiple ...
RAPS

Teva Calls on FDA to Make Copaxone a Biologic as Part of March Transition

Beginning 23 March, the US Food and Drug Administration (FDA) is going to convert more than 100 medicines approved under new drug applications (NDAs) to biologics license applications (BLAs) because ...
RAPS

US sues Teva over Copaxone co-pay assistance scheme

The US Department of Justice (DOJ) on Tuesday announced it has filed a False Claims Act complaint against Teva Pharmaceuticals USA and Teva Neuroscience, alleging the company violated anti-kickback ...

Multiple Sclerosis Market Competitive Landscape Report 2026: Comprehensive Insights on Over 60 Companies and 75 Drugs by Product Type, Development Stage, Administration Route ...

The multiple sclerosis market presents opportunities in developing innovative therapies, leveraging collaborations, and advancing clinical trials. Key players focus on new drug mechanisms and ...